keyword
https://read.qxmd.com/read/38594676/targeting-transitioning-lung-monocytes-macrophages-as-treatment-strategies-in-lung-disease-related-to-environmental-exposures
#1
JOURNAL ARTICLE
Aaron D Schwab, Todd A Wyatt, Grace Moravec, Geoffrey M Thiele, Amy J Nelson, Angela Gleason, Oliver Schanze, Michael J Duryee, Debra J Romberger, Ted R Mikuls, Jill A Poole
BACKGROUND: Environmental/occupational exposures cause significant lung diseases. Agricultural organic dust extracts (ODE) and bacterial component lipopolysaccharide (LPS) induce recruited, transitioning murine lung monocytes/macrophages, yet their cellular role remains unclear. METHODS: CCR2 RFP+ mice were intratracheally instilled with high concentration ODE (25%), LPS (10 μg), or gram-positive peptidoglycan (PGN, 100 μg) for monocyte/macrophage cell-trafficking studies...
April 9, 2024: Respiratory Research
https://read.qxmd.com/read/38171598/lower-body-mass-and-lower-adiposity-are-associated-with-differential-responses-to-two-treatment-strategies-for-rheumatoid-arthritis
#2
JOURNAL ARTICLE
Joshua F Baker, James R ODell, Bryant R England, Jon T Giles, Jefferey A Newcomb, Michael D George, Geoffrey Thiele, Larry Moreland, S Louis Bridges, Jeffrey R Curtis, Ted R Mikuls
PURPOSE: To determine if body mass index (BMI) and adipokine levels identify rheumatoid arthritis (RA) patients most likely to benefit from initiation of tumour necrosis factor inhibitors (TNFi) after methotrexate inadequate response. METHODS: This is a secondary analysis of the Rheumatoid Arthritis Comparison of Active Treatments (RACAT) trial and the (TEAR) trial. Both studies compared treatment strategies starting with conventional disease-modifying anti-rheumatic drugs (DMARDs) (triple therapy) versus etanercept plus methotrexate...
March 12, 2024: Annals of the Rheumatic Diseases
https://read.qxmd.com/read/37842953/determinants-of-achieving-serum-urate-goal-with-treat-to-target-urate-lowering-therapy-in-gout
#3
JOURNAL ARTICLE
Lindsay N Helget, James R O'Dell, Jeff A Newcomb, Maria Androsenko, Mary T Brophy, Anne Davis-Karim, Bryant R England, Ryan Ferguson, Michael H Pillinger, Tuhina Neogi, Paul M Palevsky, Hongsheng Wu, Bridget Kramer, Ted R Mikuls
OBJECTIVE: Using trial data comparing treat-to-target allopurinol and febuxostat in gout, we examined participant characteristics associated with serum urate (SU) goal achievement. METHODS: Participants with gout and SU ≥6.8 mg/dL were randomized to allopurinol or febuxostat, titrated during weeks 0 to 24, and maintained weeks 25 to 48. Participants were considered to achieve SU goal if the mean SU from weeks 36, 42, and 48 was <6.0 mg/dL or <5 mg/dL if tophi were present...
October 16, 2023: Arthritis & Rheumatology
https://read.qxmd.com/read/35947933/associations-between-shortened-telomeres-and-rheumatoid-arthritis-associated-interstitial-lung-disease-among-u-s-veterans
#4
JOURNAL ARTICLE
Jake G Natalini, Bryant R England, Joshua F Baker, Qijun Chen, Namrata Singh, Tina D Mahajan, Punyasha Roul, Geoffrey M Thiele, Brian C Sauer, Ted R Mikuls, F Bradley Johnson, Steven M Kawut
BACKGROUND: Shortened telomeres are associated with several different subtypes of interstitial lung disease (ILD), although studies of telomere length and ILD in rheumatoid arthritis (RA) are lacking. METHODS: Within the Veterans Affairs Rheumatoid Arthritis (VARA) registry, we performed cross-sectional and case-control studies of prevalent and incident ILD, respectively. We randomly selected a subset of RA patients with ILD and individually matched them to RA patients without ILD according to age, sex, and VARA enrollment date...
August 3, 2022: Respiratory Medicine
https://read.qxmd.com/read/35812446/antibodies-to-citrullinated-protein-antigens-rheumatoid-factor-isotypes-and-the-shared-epitope-and-the-near-term-development-of-clinically-apparent-rheumatoid-arthritis
#5
JOURNAL ARTICLE
Dylan T Bergstedt, Wyatt J Tarter, Ryan A Peterson, Marie L Feser, Mark C Parish, Christopher C Striebich, M Kristen Demoruelle, LauraKay Moss, Elizabeth A Bemis, Jill M Norris, V Michael Holers, Jess D Edison, Geoffrey M Thiele, Ted R Mikuls, Kevin D Deane
Background/Purpose: In rheumatoid arthritis (RA) autoantibodies including antibodies to citrullinated protein antigens (ACPA) and rheumatoid factor (RF) can be predictive of incident clinical RA. However, there is limited understanding of how antibody changes over time impact prediction of the likelihood and timing of future clinical RA. Materials and Methods: We evaluated relationships between ACPA, the shared epitope (SE), RF isotypes and incident RA in a prospective cohort of 90 ACPA(+) individuals without baseline arthritis identified through health-fair testing (i...
2022: Frontiers in Immunology
https://read.qxmd.com/read/35717175/increased-susceptibility-to-organic-dust-exposure-induced-inflammatory-lung-disease-with-enhanced-rheumatoid-arthritis-associated-autoantigen-expression-in-hla-dr4-transgenic-mice
#6
JOURNAL ARTICLE
Jill A Poole, Ted R Mikuls, Geoffrey M Thiele, Rohit Gaurav, Amy J Nelson, Michael J Duryee, Ananya Mitra, Carlos Hunter, Todd A Wyatt, Bryant R England, Dana P Ascherman
Immunogenetic as well as environmental and occupational exposures have been linked to the development of rheumatoid arthritis (RA), RA-associated lung disease, and other primary lung disorders. Importantly, various inhalants can trigger post-translational protein modifications, resulting in lung autoantigen expression capable of stimulating pro-inflammatory and/or pro-fibrotic immune responses. To further elucidate gene-environment interactions contributing to pathologic lung inflammation, we exploited an established model of organic dust extract (ODE) exposure with and without collagen-induced arthritis (CIA) in C57BL/6 wild type (WT) versus HLA-DR4 transgenic mice...
June 18, 2022: Respiratory Research
https://read.qxmd.com/read/35434725/comparative-effectiveness-of-allopurinol-and-febuxostat-in-gout-management
#7
JOURNAL ARTICLE
James R O'Dell, Mary T Brophy, Michael H Pillinger, Tuhina Neogi, Paul M Palevsky, Hongsheng Wu, Anne Davis-Karim, Jeff A Newcomb, Ryan Ferguson, David Pittman, Grant W Cannon, Thomas Taylor, Robert Terkeltaub, Amy C Cannella, Bryant R England, Lindsay N Helget, Ted R Mikuls
BACKGROUND: The relative efficacy and safety of allopurinol and febuxostat when used according to current guidelines for the treatment of hyperuricemia are unknown. This double-blind noninferiority trial examined these issues. METHODS: Participants with gout and hyperuricemia (with at least 33% having stage 3 chronic kidney disease) were randomly assigned to allopurinol or febuxostat in this 72-week trial, with doses titrated to target serum urate. The trial had three phases: titration (weeks 0 to 24), maintenance (weeks 25 to 48), and observation (weeks 49 to 72)...
March 2022: NEJM Evid
https://read.qxmd.com/read/34292726/discovery-of-iacs-9779-and-iacs-70465-as-potent-inhibitors-targeting-indoleamine-2-3-dioxygenase-1-ido1-apoenzyme
#8
JOURNAL ARTICLE
Matthew M Hamilton, Faika Mseeh, Timothy J McAfoos, Paul G Leonard, Naphtali J Reyna, Angela L Harris, Alan Xu, Michelle Han, Michael J Soth, Barbara Czako, Jay P Theroff, Pijus K Mandal, Jason P Burke, Brett Virgin-Downey, Alessia Petrocchi, Dana Pfaffinger, Norma E Rogers, Connor A Parker, Simon S Yu, Yongying Jiang, Stephan Krapp, Alfred Lammens, Graham Trevitt, Martin R Tremblay, Keith Mikule, Keith Wilcoxen, Jason B Cross, Philip Jones, Joseph R Marszalek, Richard T Lewis
Indoleamine 2,3-dioxygenase 1 (IDO1), a heme-containing enzyme that mediates the rate-limiting step in the metabolism of l-tryptophan to kynurenine, has been widely explored as a potential immunotherapeutic target in oncology. We developed a class of inhibitors with a conformationally constrained bicyclo[3.1.0]hexane core. These potently inhibited IDO1 in a cellular context by binding to the apoenzyme, as elucidated by biochemical characterization and X-ray crystallography. A SKOV3 tumor model was instrumental in differentiating compounds, leading to the identification of IACS-9779 ( 62 ) and IACS-70465 ( 71 )...
July 22, 2021: Journal of Medicinal Chemistry
https://read.qxmd.com/read/34288565/combinations-of-anticyclic-citrullinated-protein-antibody-rheumatoid-factor-and-serum-calprotectin-positivity-are-associated-with-the-diagnosis-of-rheumatoid-arthritis-within-3-years
#9
JOURNAL ARTICLE
Leah F Bettner, Ryan A Peterson, Dylan T Bergstedt, Lindsay B Kelmenson, M Kristen Demoruelle, Ted R Mikuls, Jess D Edison, Mark C Parish, Marie L Feser, Ashley A Frazer-Abel, Laura K Moss, Michael Mahler, V Michael Holers, Kevin D Deane
OBJECTIVE: To evaluate the prevalence of elevations of anti-cyclic citrullinated peptide-3 (anti-CCP3) antibody, rheumatoid factor IgM (RF-IgM) and serum calprotectin (sCP) in pre-rheumatoid arthritis (RA) as well as the diagnostic accuracies of these biomarkers for the timing of diagnosis of future RA. METHODS: A total of 215 RA cases, each with approximately three pre-RA diagnoses and one post-RA diagnosis serum sample, and controls were identified from the Department of Defense Serum Repository...
October 2021: ACR open rheumatology
https://read.qxmd.com/read/33577605/high-throughput-analysis-of-lung-immune-cells-in-a-combined-murine-model-of-agriculture-dust-triggered-airway-inflammation-with-rheumatoid-arthritis
#10
JOURNAL ARTICLE
Rohit Gaurav, Ted R Mikuls, Geoffrey M Thiele, Amy J Nelson, Meng Niu, Chittibabu Guda, James D Eudy, Austin E Barry, Todd A Wyatt, Debra J Romberger, Michael J Duryee, Bryant R England, Jill A Poole
Rheumatoid arthritis (RA)-associated lung disease is a leading cause of mortality in RA, yet the mechanisms linking lung disease and RA remain unknown. Using an established murine model of RA-associated lung disease combining collagen-induced arthritis (CIA) with organic dust extract (ODE)-induced airway inflammation, differences among lung immune cell populations were analyzed by single cell RNA-sequencing. Additionally, four lung myeloid-derived immune cell populations including macrophages, monocytes/macrophages, monocytes, and neutrophils were isolated by fluorescence cell sorting and gene expression was determined by NanoString analysis...
2021: PloS One
https://read.qxmd.com/read/32391934/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout
#11
JOURNAL ARTICLE
John D FitzGerald, Nicola Dalbeth, Ted Mikuls, Romina Brignardello-Petersen, Gordon Guyatt, Aryeh M Abeles, Allan C Gelber, Leslie R Harrold, Dinesh Khanna, Charles King, Gerald Levy, Caryn Libbey, David Mount, Michael H Pillinger, Ann Rosenthal, Jasvinder A Singh, James Edward Sims, Benjamin J Smith, Neil S Wenger, Sangmee Sharon Bae, Abhijeet Danve, Puja P Khanna, Seoyoung C Kim, Aleksander Lenert, Samuel Poon, Anila Qasim, Shiv T Sehra, Tarun Sudhir Kumar Sharma, Michael Toprover, Marat Turgunbaev, Linan Zeng, Mary Ann Zhang, Amy S Turner, Tuhina Neogi
OBJECTIVE: To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. METHODS: Fifty-seven population, intervention, comparator, and outcomes questions were developed, followed by a systematic literature review, including network meta-analyses with ratings of the available evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, and patient input...
June 2020: Arthritis Care & Research
https://read.qxmd.com/read/32390306/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout
#12
JOURNAL ARTICLE
John D FitzGerald, Nicola Dalbeth, Ted Mikuls, Romina Brignardello-Petersen, Gordon Guyatt, Aryeh M Abeles, Allan C Gelber, Leslie R Harrold, Dinesh Khanna, Charles King, Gerald Levy, Caryn Libbey, David Mount, Michael H Pillinger, Ann Rosenthal, Jasvinder A Singh, James Edward Sims, Benjamin J Smith, Neil S Wenger, Sangmee Sharon Bae, Abhijeet Danve, Puja P Khanna, Seoyoung C Kim, Aleksander Lenert, Samuel Poon, Anila Qasim, Shiv T Sehra, Tarun Sudhir Kumar Sharma, Michael Toprover, Marat Turgunbaev, Linan Zeng, Mary Ann Zhang, Amy S Turner, Tuhina Neogi
OBJECTIVE: To provide guidance for the management of gout, including indications for and optimal use of urate-lowering therapy (ULT), treatment of gout flares, and lifestyle and other medication recommendations. METHODS: Fifty-seven population, intervention, comparator, and outcomes questions were developed, followed by a systematic literature review, including network meta-analyses with ratings of the available evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology, and patient input...
June 2020: Arthritis & Rheumatology
https://read.qxmd.com/read/32224441/immunogenic-and-inflammatory-responses-to-citrullinated-proteins-are-enhanced-following-modification-with-malondialdehyde-acetaldehyde-adducts
#13
JOURNAL ARTICLE
Geoffrey M Thiele, Michael J Duryee, Carlos D Hunter, Bryant R England, Benjamin S Fletcher, Eric C Daubach, Taylor P Pospisil, Lynell W Klassen, Ted R Mikuls
BACKGROUND/OBJECTIVE: Malondialdehyde-acetaldehyde adducts (MAA) act as potent immune adjuvants and co-localize with citrullinated antigens in tissues effected by rheumatoid arthritis (RA). We sought to examine the role of MAA-adducts in promoting RA-related autoimmunity and inflammation. METHODS: DBA/J1 mice were immunized with human serum albumin (HSA), HSA-MAA, citrullinated HSA (HSA-Cit), or HSA-MAA-Cit with subsequent measurement of serum anti-citrullinated protein antibody (ACPA) and anti-Cit T cell responses...
June 2020: International Immunopharmacology
https://read.qxmd.com/read/31464042/timing-of-elevations-of-autoantibody-isotypes-prior-to-diagnosis-of-rheumatoid-arthritis
#14
JOURNAL ARTICLE
Lindsay B Kelmenson, Brandie D Wagner, Bryan K McNair, Ashley Frazer-Abel, M Kristen Demoruelle, Dylan T Bergstedt, Marie L Feser, Laura K Moss, Mark C Parish, Elizabeth A Mewshaw, Ted R Mikuls, Jess D Edison, V Michael Holers, Kevin D Deane
OBJECTIVE: To evaluate patterns of elevations of isotypes of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) pre-rheumatoid arthritis (RA) diagnosis and post-RA diagnosis. METHODS: Using the Department of Defense Serum Repository we identified 214 RA cases and 210 matched controls. Up to 3 pre-RA diagnosis and 1 post-RA diagnosis serum samples per subject were tested for RF and for IgA, IgG, and IgM ACPAs. The timing and trajectories of elevations of autoantibodies were evaluated...
February 2020: Arthritis & Rheumatology
https://read.qxmd.com/read/30933423/malondialdehyde-acetaldehyde-adducts-and-antibody-responses-in-rheumatoid-arthritis-associated-interstitial-lung-disease
#15
JOURNAL ARTICLE
Bryant R England, Michael J Duryee, Punyasha Roul, Tina D Mahajan, Namrata Singh, Jill A Poole, Dana P Ascherman, Liron Caplan, M Kristen Demoruelle, Kevin D Deane, Lynell W Klassen, Geoffrey M Thiele, Ted R Mikuls
OBJECTIVE: To compare serum anti-malondialdehyde-acetaldehyde (anti-MAA) antibody levels and MAA expression in lung tissue from patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD) to those found in controls. METHODS: Anti-MAA antibody (IgA, IgM, IgG) concentrations were measured in patients with RA-ILD and compared to those of RA patients with chronic obstructive pulmonary disease (COPD) and RA patients without lung disease. Associations between anti-MAA antibody with RA-ILD were assessed using multivariable logistic regression...
September 2019: Arthritis & Rheumatology
https://read.qxmd.com/read/30777365/post-traumatic-stress-disorder-and-serum-cytokine-and-chemokine-concentrations-in-patients-with-rheumatoid-arthritis-%C3%A2
#16
JOURNAL ARTICLE
P M Maloley, B R England, H Sayles, G M Thiele, K Michaud, J Sokolove, G W Cannon, A M Reimold, G S Kerr, J F Baker, L Caplan, A J Case, T R Mikuls
OBJECTIVE: Although post-traumatic stress disorder (PTSD) is identified as a risk factor in the development of rheumatoid arthritis (RA), associations of PTSD with disease progression are less clear. To explore whether PTSD might influence disease-related measures of systemic inflammation in RA, we compared serum cytokine/chemokine (cytokine) concentrations in RA patients with and without PTSD. METHODS: Participants were U.S. Veterans with RA and were categorized as having PTSD, other forms of depression/anxiety, or neither based on administrative diagnostic codes...
October 2019: Seminars in Arthritis and Rheumatism
https://read.qxmd.com/read/30506404/evaluation-of-cytokine-profiles-in-rheumatoid-arthritis-patients-with-clinically-active-disease-and-normal-inflammatory-indices
#17
JOURNAL ARTICLE
Asha M Alex, Harlan Sayles, Ted R Mikuls, Gail S Kerr
OBJECTIVE: To assess the potential utility of a cytokine measurement in rheumatoid arthritis (RA) patients with active joint disease but normal acute phase reactants (APR). METHODS: RA patients in a longitudinal observational registry with available cytokine array data were included. Patients were categorized based on agreement/disagreement of physical examination and APR measurements: concordant high (CH) [high tender and/or swollen joint counts (TJC + SJC > 3) and APR (ESR ≥ 28 mm/h + CRP ≥ 1...
December 1, 2018: Clinical Rheumatology
https://read.qxmd.com/read/30503879/adherence-and-outcomes-with-urate-lowering-therapy-a-site-randomized-trial
#18
RANDOMIZED CONTROLLED TRIAL
Ted R Mikuls, T Craig Cheetham, Gerald D Levy, Nazia Rashid, Artak Kerimian, Kimberly J Low, Brian W Coburn, David T Redden, Kenneth G Saag, P Jeffrey Foster, Lang Chen, Jeffrey R Curtis
PURPOSE: The purpose of this study was to test a pharmacist-led intervention to improve gout treatment adherence and outcomes. METHODS: We conducted a site-randomized trial (n=1463 patients) comparing a 1-year, pharmacist-led intervention to usual care in patients with gout initiating allopurinol. The intervention was delivered primarily through automated telephone technology. Co-primary outcomes were the proportion of patients adherent (proportion of days covered ≥0...
March 2019: American Journal of Medicine
https://read.qxmd.com/read/30447534/antioxidant-properties-of-citric-acid-interfere-with-the-uricase-based-measurement-of-circulating-uric-acid
#19
COMPARATIVE STUDY
Evan M Ryan, Michael J Duryee, Andrew Hollins, Susan K Dover, Samuel Pirruccello, Harlan Sayles, Kevin D Real, Carlos D Hunter, Geoffrey M Thiele, Ted R Mikuls
BACKGROUND: Circulating uric acid (UA) is an important biomarker, not only in the detection and management of gout, but also in assessing the risk of related comorbidity. The impact of collection methods on clinical UA measurements has been the subject of limited study. After observing significant differences between UA concentrations of blood samples obtained by different collection tubes, we began examining the effects of exogenous tube components on measured UA concentrations. We aimed to: (1) demonstrate the variability in uricase-based UA measurements attributable to different collection methods and (2) identify factors influencing this variability...
February 5, 2019: Journal of Pharmaceutical and Biomedical Analysis
https://read.qxmd.com/read/30297535/pharmacological-inhibition-of-parp6-triggers-multipolar-spindle-formation-and-elicits-therapeutic-effects-in-breast-cancer
#20
JOURNAL ARTICLE
Zebin Wang, Shaun E Grosskurth, Tony Cheung, Philip Petteruti, Jingwen Zhang, Xin Wang, Wenxian Wang, Farzin Gharahdaghi, Jiaquan Wu, Nancy Su, Ryan T Howard, Michele Mayo, Dan Widzowski, David A Scott, Jeffrey W Johannes, Michelle L Lamb, Deborah Lawson, Jonathan R Dry, Paul D Lyne, Edward W Tate, Michael Zinda, Keith Mikule, Stephen E Fawell, Corinne Reimer, Huawei Chen
: PARP proteins represent a class of post-translational modification enzymes with diverse cellular functions. Targeting PARPs has proven to be efficacious clinically, but exploration of the therapeutic potential of PARP inhibition has been limited to targeting poly(ADP-ribose) generating PARP, including PARP1/2/3 and tankyrases. The cancer-related functions of mono(ADP-ribose) generating PARP, including PARP6, remain largely uncharacterized. Here, we report a novel therapeutic strategy targeting PARP6 using the first reported PARP6 inhibitors...
December 1, 2018: Cancer Research
keyword
keyword
90504
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.